Northeast Investment Management Becton Dickinson & CO Transaction History

Northeast Investment Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$232.09 - $256.88 $188,457 - $208,586	-812 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$221.92 - $245.94 $13,980 - $15,494	-63 Reduced 7.2%	812 $203,000
Q2 2020 Aug 11, 2020	BUY	$219.9 - $263.41 $192,412 - $230,483	875 New	875 $209,000
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $201,365 - $287,101	-1,029 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$236.45 - $266.82 $35,467 - $40,023	-150 Reduced 12.72%	1,029 $280,000
Q2 2019 Aug 12, 2019	SELL	$217.4 - $246.08 $34,784 - $39,372	-160 Reduced 11.95%	1,179 $297,000
Q1 2019 May 14, 2019	SELL	$206.05 - $248.17 $27,404 - $33,006	-133 Reduced 9.04%	1,339 $334,000
Q2 2018 Aug 13, 2018	SELL	$208.1 - $233.85 $8,324 - $9,354	-40 Reduced 2.65%	1,472 $353,000
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $34,517 - $40,365	-168 Reduced 10.0%	1,512 $328,000
Q4 2017 Jan 29, 2018	SELL	$189.0 - $222.64 $311,661 - $367,133	-1,649 Reduced 49.53%	1,680 $360,000
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $622,156 - $662,138	3,329	3,329 $652,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

Stay updated on Northeast Investment Management with notifications on news.